Table 3 Impact of NIHR HTA studies on NICE Clinical Guidelines (CGs)
From: Impact of NIHR HTA Programme funded research on NICE clinical guidelines: a retrospective cohort
Category | Criteria | CGs | Total (%) |
|---|---|---|---|
1 | CG based on the updating of previous NIHR HTA journal(s) | CG7, CG19, CG29 | 3 (2%) |
2 | CG drew on the evidence from previously published NIHR HTA funded studies | CG3, 8,9 10,11, 15,16, 17, 21, 25, 26, 27, 28, 30, 31, 32, 35, 36, 37, 38, 39, 42, 43, 44, 45, 47, 48, 49, 51, 52, 53, 54, 57, 58, 59, 61, 62, 63, 65, 66, 67, 68, 71, 72, 73, 74, 76, 77, 78, 79, 80, 81, 82, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 101, 102, 103, 105, 106, 107, 108, 109, 113, 117, 121, 122, 123, 124, 126, 127, 131, 132, 133, 135, 136, 137, 138, 139 | 90 (74%) |
3 | No NIHR HTA studies were cited | CG41, 50, 55, 56, 60, 64, 69, 70, 75, 83, 84, 98, 99, 100, 104, 110, 111, 112, 114, 115, 116, 118, 119, 120, 125, 128, 129, 130, 134 | 29 (24%) |